Clindoxyl® Gel (Clindamycin phosphate and benzoyl peroxide) - A - Detailing from Skin Therapy Letter

 

Clindoxyl® Gel (Clindamycin phosphate and benzoyl peroxide)

 

 

  Content:

INTRODUCTION

 

 

  • Agents such as benzoyl peroxide, clindamycin and erythromycin have been the mainstay of topical acne therapy
  • Consideration in the development and selection of newer topical anti-acne combinations include
    • Efficacy
    • Compliance
    • Reducing the risk of antibiotic resistance.

There are limitations for regulators, pharmaceutical companies and pharmaceutical sales representatives to present clinical evidence following development of product monograph and drug approval. The product monograph is the starting point for this A-Detail™. It also contains evidence-based decision making processes, current standards of practice and clinical experience to provide a practical approach to the treatment of this condition.

Disclaimer: This A-Detail™ is meant to be a practical guide and does not necessarily reflect all risks, side-effects or situations associated with this product.


Next:   Clinical Exerience